James G. Hall - 01 Jun 2023 Form 4 Insider Report for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
05 Jun 2023, 15:27:49 UTC
Prior SEC filing
15 Aug 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Rebecca Hilt, Attorney-In-Fact for James Hall

Key filing fact

James G. Hall filed Form 4 for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) on 05 Jun 2023.

Key facts

  • This page summarizes James G. Hall's Form 4 filing for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 05 Jun 2023, 15:27.

Change

  • Previous filing in this sequence was filed on 15 Aug 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LFCR transaction

Common Stock

Award

Transaction value
Shares
+150,000
Change %
+294%
Price
Shares after
201,096
Date
01 Jun 2023
Ownership
Direct
Footnotes
F1, F2
LFCR transaction

Common Stock

Award

Transaction value
Shares
+75,000
Change %
+37%
Price
Shares after
276,096
Date
01 Jun 2023
Ownership
Direct
Footnotes
F1, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.

Footnote F2

Restricted Stock Units will vest on the 3rd anniversary of the grant date.

Footnote F3

Restricted Stock Units will vest on the 3rd anniversary of the grant date or if earlier, upon a Change in Control.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .